Drawing for ENDOTIS

USPTO serial 76524721

ENDOTIS

Reviewed by CopyMark Law Group

Reg. 3003237Status 710
Filing date
Status date
Registration date
Oct 4, 2005
Examiner
FAINT, MARY CATHERINE
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.

Status 710: Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active.

Need help with ENDOTIS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Mark Lebow

Mark Lebow YOUNG & THOMPSON209 Madison StreetSuite 500Alexandria, VA 22314

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations and veterinary preparations; molecules for therapeutic use, namely, proteins, peptides, nucleic acids, small synthetic molecules, in particular for the treatment of cancer and inflammatory pathologies, especially aggressive and metastasis cancer and acute inflammatory pathologies; diagnostic products, namely reagents, biological and pharmaceutical preparations for detecting the presence or evaluating the progression of a disease, for evaluating the response to a treatment or the prognosis of a patient outcome; biological preparations for medical, pharmaceutical or veterinary purposes for the treatment of cancer, inflammatory pathologies, and neurodegenerative diseases; culture medium for bacteriological use, nutritive substances for microorganisms; cell preparations for medical, pharmaceutical or veterinary purposes and particularly for gene therapy and cell therapySECTION 8 - CANCELLED
042Scientific work relating to basic research and applied research in particular in biopharmaceutical and bacteriological processing; research and development of new products for others, in particular, research and development of molecules for pharmaceutical industries; conducting screening tests to identify, characterize, validate or develop biologically active molecules; advising and consultancy in scientific field; licensing of intellectual property rights for others; quality control servicesSECTION 8 - CANCELLED

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Sep 21, 2012C8..CANCELLED SEC. 8 (6-YR)
Mar 16, 2008TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED
Oct 4, 2005R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jul 12, 2005PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jun 22, 2005NPUBNOTICE OF PUBLICATION
Jan 10, 2005ALIEASSIGNED TO LIE
Jan 8, 2005PREVLAW OFFICE PUBLICATION REVIEW COMPLETED
Jan 7, 2005ALIEASSIGNED TO LIE
Jan 4, 2005CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
Jan 4, 2005TEMETEAS/EMAIL CORRESPONDENCE ENTERED
Dec 21, 2004CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 21, 2004TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 24, 2004CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 25, 20041.BDSec. 1(B) CLAIM DELETED
May 25, 2004CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
May 25, 2004CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
May 25, 2004MAILPAPER RECEIVED
Nov 25, 2003CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 19, 2003DOCKASSIGNED TO EXAMINER

Frequently asked questions

Related guidance